NCT01853215

Brief Summary

This study is being done to evaluate intraosseous vascular access through the sternum.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 9, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 14, 2013

Completed
5 months until next milestone

Results Posted

Study results publicly available

October 18, 2013

Completed
Last Updated

December 24, 2025

Status Verified

December 1, 2025

Enrollment Period

1 month

First QC Date

May 9, 2013

Results QC Date

June 6, 2013

Last Update Submit

December 7, 2025

Conditions

Keywords

sternal intraosseous infusion study

Outcome Measures

Primary Outcomes (1)

  • Occurrences of Extravasation During Infusion

    The number of participants with occurrence of extravasation during intraosseous infusion as evidenced by contrast injection into the intraosseous catheter, visualized under fluoroscopic imaging.

    during 12 minutes of infusion

Secondary Outcomes (7)

  • Stability of Locator

    During insertion of the intraosseous needle set

  • Stability of Catheter Hub

    During insertion of the intraosseous needle set

  • Adhesion Strips

    During insertion of the intraosseous needle set

  • Gravity Flow Rates

    during the 12 minute infusion time frame

  • 100 Millimeters of Mercury (mmHg) Infusion Flow Rates

    during the 12 minute infusion time frame

  • +2 more secondary outcomes

Study Arms (1)

Sternal intraosseous vascular access

EXPERIMENTAL

Sternal intraosseous vascular access using T.A.L.O.N. Intraosseous System.

Device: T.A.L.O.N. Intraosseous System

Interventions

intraosseous catheter for use in the sternum

Also known as: EZ-IO TALON
Sternal intraosseous vascular access

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older;
  • healthy adult subjects

You may not qualify if:

  • Weight \< 45kg;
  • BMI greater or equal to 30 with absence of adequate landmarks or too much overlaying tissue, as determined by the PI;
  • Imprisoned subjects;
  • pregnant subjects;
  • prior sternotomy;
  • cognitively impaired subjects;
  • fracture in target bone, or significant trauma to the site;
  • excessive tissue and/or absence of adequate anatomical landmarks in target bone;
  • infection in target area;
  • IO insertion in past 48 hours or other significant orthopedic procedure in target bone;
  • current use of anti-coagulants;
  • previous adverse reaction to Lidocaine;
  • current cardiac condition requiring pacemaker or anti-arrhythmic drugs
  • previous adverse reaction to contrast dye
  • Allergy to any food and drug
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bulverde-Spring Branch EMS

Spring Branch, Texas, 78070, United States

Location

Results Point of Contact

Title
Larry J. Miller, MD
Organization
Vidacare Corporation

Study Officials

  • Larry J Miller, MD

    Vidacare Corporation

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2013

First Posted

May 14, 2013

Study Start

April 1, 2013

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

December 24, 2025

Results First Posted

October 18, 2013

Record last verified: 2025-12

Locations